HER2 Proven Diagnostic Accuracy

Since 1998, laboratories around the world have relied on the diagnostic accuracy of Dako HER2 testing for breast cancer. Now new hope is given for patients with gastric cancer. A recent clinical study shows that HercepTest™ and HER2 FISH pharmDx™ Kit accurately identify patients with gastric cancer who may benefit from trastuzumab treatment.*

HER2 treatment now targets both patients with breast and gastric cancer indications.

HER2 Gastric

*Lancet 2010; 376:687-07

Country selection

Your Dako Account indicates that you are based in , you will be transfered to the web site for

Basket emptied

Your basket was emptied because of the country change.

Country selection

United States of America appears to be your location. To view country specific information on the Dako web site, please accept or change country below.


Dako Cookie Policy
This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. Privacy Statement



Get in Touch with Dako in Luxemburg

Contact Us Directly

info.be@dako.com
+32 016/38.72.20
+32 016/38.72.21

Pathology Products, Flow Cytometry Products and Specific Proteins
Please inquire at
Dako Belgium N.V.

Interleuvenlaan 12B
B-3001 Heverlee
Belgium

Detailed contact information

Submit an Inquiry

How would you like us to follow up?


Your session expired

You have been logged out. Log in again to retrieve your Cart.